Atlas Venture
Steven Sweeney is an accomplished leader in the pharmaceutical and clinical development sectors, currently serving as an Entrepreneur in Residence at Atlas Venture since March 2025. As the President and CEO of Integrity Clinical Services, LLC since January 2012, Steven has a wealth of experience in managing clinical operations. Prior to his current role at Atlas Venture, Steven held key positions at Aliada Therapeutics as President and Chief Operating Officer until its acquisition by Abbvie, and at Third Harmonic Bio, where Steven served as EVP and then SVP of Clinical Development Operations. Steven's educational background includes a Bachelor of Science in Toxicology, Pharmaceuticals, and Pharmacy from Northeastern University, earned in January 1996.
This person is not in any teams
This person is not in any offices
Atlas Venture
Atlas Venture is a leading biotech venture capital firm. With the goal of doing well by doing good, they have been building breakthrough biotech startups since 1993. They work side by side with exceptional scientists and entrepreneurs to translate high impact science into medicines for patients. Their seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value.